2027 Biomedical HIV Prevention Summit Abstracts for iPosters!

The 2027 Biomedical HIV Prevention Summit program committee has issued the Call for Abstracts to solicit proposals from people interested in submitting an iPoster at the Summit. 

When preparing abstracts, please follow all guidelines outlined in this site and submit required materials by November 23, 2026. The committee will notify those accepted proposals well in advance of the conference dates and send them information concerning all applicable registration and iPoster details.

What is an Abstract?

A conference abstract is a document that pitches a presentation, workshop or poster for a conference. It outlines the topic, approach, and how the session will benefit attendees. The goal is to convince the program planning committee that the session is relevant and valuable to their audience. 

An abstract is a powerful way to share your skills, ideas, and experiences with the diverse community that comes together at the Summit. It offers a clear structure to present your work in a way that is engaging, accessible, and meaningful across disciplines, roles, and lived experiences. We encourage you to review the six tracks for the 2027 Summit and submit an abstract that aligns with one of these areas. 

What is an iPoster?

A poster (iPoster) is an interactive digital format that allows participants to share their work in a clear, visually engaging way. Unlike traditional printed posters, iPosters can include multimedia elements such as images, charts, and videos, giving attendees the opportunity to explore content at their own pace.

Posters are best suited for summarizing programs, projects, research findings, or community initiatives in a concise and accessible format. Participants should focus on key messages, practical insights, and clear visuals that make the content easy to understand for a broad audience.

iPosters are available for viewing throughout the conference, and may also have designated times to engage with attendees, answer questions, and discuss their work.

2027 Summit Tracks

The 2027 Biomedical HIV Prevention Summit theme is “Future Forward: The Next Era of HIV Prevention,” and tracks are aligned with this theme. You can pick any of these tracks to base your abstract on. While you can submit multiple abstracts, you have to select one track for each abstract. 

TRACK 1

Delivering Today’s Biomedical Prevention Tools

This track examines how current and emerging HIV prevention tools are delivered in the real world, including U=U, HIV testing, linkage and partner services, oral and long-acting PrEP, PEP, diagnostics, and combination prevention. Sessions should connect evidence on safety and effectiveness with community experience, informed choice, access, uptake, and persistence.

What to include in your abstract: We encourage submissions that describe how HIV prevention tools are delivered in real-world settings, connecting evidence on safety and effectiveness with community experience and informed choice, and sharing strategies that improve access, uptake, and persistence.

USCHA 2026

TRACK 2

Applied Public Health, Implementation and Program Science

This track uses surveillance, epidemiology, implementation science, and program evaluation to strengthen prevention programs. It includes data modernization and integration, modeling, cluster and outbreak response, quality improvement, dissemination, and scale-up. Sessions should address community participation in data priorities, interpretation, privacy, trust, and communication.

What to include in your abstract: We encourage submissions that apply surveillance, epidemiology, implementation science, or program evaluation to strengthen prevention programs, and that describe how communities take part in setting data priorities, interpreting findings, and protecting privacy and trust.

TRACK 3

Community Leadership, Youth, and Lived Experience in Prevention Science

This track explores how community leadership, youth perspectives, and lived experience shape prevention research, program design, implementation, evaluation, and communication. It includes community-based participatory research, community-led program science, peer-driven models, co-design, ethical use of data, shared decision-making, and investment in community leadership.

What to include in your abstract: We encourage submissions that show how community leaders, young people, and people with lived experience shape prevention research and programs through participatory research, peer-driven models, co-design, or shared decision-making, and how that leadership is sustained.

USCHA 2026

TRACK 4

Workforce and Integrated Prevention Systems

This track examines how multidisciplinary teams and community-informed systems integrate HIV prevention with related health and social services. It focuses on workforce development and well-being, team-based care, cross-sector partnerships, and coordinated services to deliver low-barrier, affirming, whole-person prevention and improve measurable outcomes.

What to include in your abstract: We encourage submissions that describe how workforce development, team-based care, and cross-sector partnerships integrate HIV prevention with related health and social services to deliver low-barrier, affirming, whole-person prevention with measurable outcomes.

TRACK 5

Access, Policy, Financing, and Sustainability

This track examines how policy, financing, and structural conditions affect prevention access and sustainability. It includes public health law, insurance, Medicaid, reimbursement, 340B, grants, procurement, cost-effectiveness, implementation economics, and resource allocation. Sessions should address real-world effects on people and community organizations and strategies to reduce structural inequities.

What to include in your abstract: We encourage submissions that examine how policy, financing, and structural conditions affect access to prevention and program sustainability, and that share practical strategies to reduce structural inequities for people and community organizations.

USCHA 2026

TRACK 6

Sexual Health and STI Prevention for All

This track focuses on clinical, epidemiologic, and program science for sexual health and STI prevention across the lifespan and diverse populations. It includes STI surveillance, screening, diagnostics, treatment, doxy-PEP, vaccination, partner services, antimicrobial resistance, guidelines, delivery models, and sexual health communication, emphasizing affirming, confidential care and shared decision-making.

What to include in your abstract: We encourage submissions that advance sexual health and STI prevention across the lifespan and diverse populations, including screening, diagnostics, treatment, doxy-PEP, vaccination, partner services, and delivery models that offer affirming, confidential care and support shared decision-making.

Abstract Development Guidelines

  1. Titles are Limited to 20 words or less
  2. iPoster descriptions are limited to 100 words. This description, if accepted, will be used on all official publications.
  3. Abstract Formats
    1. Scientific based
    2. Community Based
  4. iPoster Platform: iPosters will be developed in a platform provided by NMAC.
  5. iPoster Levels: Indicate the intended level (novice, intermediate, advanced) based on the knowledge and experience required for participants to engage with the content. 
  6. Tracks: A range of tracks is available. Abstracts may be submitted to one track only, based on the best fit.
  7. Abstracts must be non-promotional and aligned with the scientific and community focus of the 2027 Summit. Submissions primarily intended to market or promote a product will not be accepted. All relevant financial relationships must be disclosed. Abstracts led solely by pharmaceutical industry representatives are not eligible for iPosters but may be considered if they include meaningful collaboration with community, public health, or academic partners.

Abstract Submission Tips

  1. Start Early: Give yourself enough time to plan, write, and revise your abstract.
  2. Choose a  topic you know well. Focus on a program, project, or issue you have direct experience with or knowledge about. 
  3. Select the best track. Review the 2027 Summit track topics and choose the one that best fits your submission.
    1. Submit your abstract to one track only.
    2. Do not submit the same abstract more than once
  4. Submit completed work. We encourage abstracts that include final results or clear outcomes. “Work in progress” submissions are discouraged.
  5. Prepare your abstract before submitting. Write and save your abstract in a document (such as Word) before entering it into the submission system.
  6. Use clear language.
    1. Spell out acronyms the first time you use them
    2. Avoid jargon or unclear terms
    3. Be direct and stay focused on your main points
  7. Write clear learning objectives. Describe what participants will learn from your session (for example, skills, knowledge, or strategies they can apply).
  8. Review and edit carefully.
    1. Check for spelling and grammar errors
    2. Make sure your ideas are easy to understand
  9. Ask for feedback. Have a colleague, collaborator, or community partner review your abstract to ensure it is clear and concise.

2027 Biomedical H.I.V. Prevention Summit - April 28 - 30 - Orlando Florida

Decisions will be sent to all applicants on December 21, 2026. Some iPosters will be selected for presentation. Please check your spam and junk folders to ensure you get the Abstract notification email. 

Selected applicants will need to secure their own travel, accommodations, and registration. It is suggested you plan ahead so that you can take advantage of early bird registration.


Poster materials will be displayed on a screen supplied by NMAC. Since an iPoster format is best when your material can easily be communicated visually, text should be limited to brief statements.

  • The iPoster should make a unified, coherent statement
  • Materials, both text and visual, should be of professional quality and be clearly legible.
  • Incorporate visuals such as charts, images, and graphics to enhance understanding and engagement.
  • Ensure all multimedia elements (videos, audio, links) are properly embedded and functioning before final submission.

Contact

For information, updates, and questions about NMAC’s 2027 Biomedical HIV Prevention Summit, please email Conferences@NMAC.org